Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial
R. E. Ratner, J. Rosenstock, G. Boka, on behalf of the DRI6012 Study InvestigatorsVolume:
27
Year:
2010
Language:
english
Pages:
9
DOI:
10.1111/j.1464-5491.2010.03020.x
File:
PDF, 202 KB
english, 2010